Sakurai Keiko

サクライケイコ | Sakurai Keiko

Affiliation and department：

Research keywords (3)：医療政策 , 医療経済 , 精神保健

Research theme for competitive and other funds (3)：

2024 - 2027 糖尿病及び腎疾患の発症/増悪の関連要因の同定と健康アウトカムへの影響に関する研究
2021 - 2022 新型コロナウイルス感染症(COVID-19)に関する情報の取得方法やその理解に関する実態把握と予防(ワクチン接種等)に及び受療行動の支援に関する研究
2020 - 2021 COVID-19抗体検査を用いた抗体保有の実態把握に関する研究

Papers (22)：

Keiko Maruyama-Sakurai, Hisateru Tachimori, Eiko Saito, Shun Kohsaka, Yasumasa Segawa, Hiroaki Miyata, Ataru Igarashi. Cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in the treatment of diabetic nephropathy in Japan. Diabetes, obesity & metabolism. 2024
Mami Ueta, Alton Cao, Michio Murakami, Hana Tomoi, Stuart Gilmour, Keiko Maruyama-Sakurai, Yoshihiro Takayama, Yoshitake Takebayashi, Masahiro Hashizume, Rauniyar Santosh Kumar, et al. Factors influencing parental COVID-19 vaccination willingness for children in Japan. Vaccine: X. 2024. 100528-100528
Shuhei Nomura, Akifumi Eguchi, Keiko Maruyama-Sakurai, Ruka Higashino, Daisuke Yoneoka, Takayuki Kawashima, Yuta Tanoue, Yumi Kawamura, Rauniyar Santosh Kumar, Takanori Fujita, et al. Characterizing Healthy Dietary Practices in Japan: Insights from a 2024 Nationwide Survey and Cluster Analysis. Nutrients. 2024
Alton Cao, Mami Ueta, Manae Uchibori, Michio Murakami, Hiroyuki Kunishima, Rauniyar Santosh Kumar, Prapichaya Prommas, Hana Tomoi, Stuart Gilmour, Haruka Sakamoto, et al. Trust in governments, public health institutions, and other information sources as determinants of COVID-19 vaccine uptake behavior in Japan. Vaccine. 2024
Manae Uchibori, Cyrus Ghaznavi, Michio Murakami, Akifumi Eguchi, Hiroyuki Kunishima, Satoshi Kaneko, Keiko Maruyama-Sakurai, Hiroaki Miyata, Shuhei Nomura. Preventive Behaviors and Information Sources during COVID-19 Pandemic: A Cross-Sectional Study in Japan. International journal of environmental research and public health. 2022. 19. 21

ｍore...

MISC (3)：

五十嵐中, 櫻井桂子, 窪田杏奈, 坂元晴香, 秋山博紀, 森田奈瑠, 木谷曜子, 矢島利高, 宮田裕章. 糖尿病治療第一選択薬としてのSGLT2阻害薬の費用効果分析. 糖尿病. 2022. 65. Suppl.1. S-193
新城大輔, 立森久照, 櫻井桂子, 伏見清秀. 大規模医療データからみた急性期病院における精神患者の在院日数と計画的でない再入院. 精神神経学雑誌. 2016. 2016特別号. S645-S645
櫻井桂子, 野口麻衣子, 吉江悟, 古田達之, 飯島勝矢, 山中崇. 「在宅医療・介護従事者の顔の見える関係づくりを目指した研修会」の効果検証. 日本老年医学会雑誌. 2015. 52. Suppl. 123-123

Lectures and oral presentations (3)：

Cost-effectiveness of SGLT2 inhibitors for the treatment of type 2 diabetes and its complication
(The 60th European Renal Association Congress 2023)
COVID-19 Preventive Behaviours and Information Sources: A Cross-sectional Study in Japan
(17th WORLD CONGRESS ON PUBLIC HEALTH 2023)
糖尿病治療第一選択薬としてのSGLT2阻害薬の費用効果分析
(第65回日本糖尿病学会年次学術集会 2022)

Work history (8)：

2024/04 - 現在 Keio University School of Medicine, Department of Health Policy and Management
2020/04 - 2024/03 Keio University School of Medicine Department of Health Policy and Management
2022/07 - 2022/12 WHO西太平洋事務局コンサルタント
2022/02 - 2022/04 WHO西太平洋事務局コンサルタント
2018/11 - 2020/06 National Center of Neurology and Psychiatry

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page